About me
Experienced healthcare professional with over two decades of experience leading evidence generation strategies and research at some of the world’s most prestigious pharmaceutical and health technology companies. As Chief Medical Officer at PharmaMar, I drive the integration clinical research, real-world evidence, outcome research, and patient safety to support the development of groundbreaking marine-derived therapies and optimize clinical and regulatory processes.
Throughout my career, I have held strategic roles at companies such as Flatiron Health, Syneos Health, Sanofi, and AstraZeneca. This journey has provided me with a comprehensive, multidisciplinary perspective on clinical development, medical affairs and market access empowering me to spearhead high-impact projects that enhance clinical practice and promote data-driven decision-making.
At PharmaMar, my commitment is to translate cutting-edge science into tangible clinical benefits. In my role as Chief Medical Officer, I lead the development of innovative strategies that ensure our unique therapies meet the highest standards of safety and efficacy, which reinforces PharmaMar's mission to offer innovative marine-derived oncological treatments for patients with limited therapeutic options.
